Medical devices that need a clinical investigation

AI Summary

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance to assist manufacturers in determining whether a clinical investigation is required for their products under the UK Medical Device Regulations 2002 (SI 2002, No 618, as amended). This regulatory framework specifically applies to general medical devices and active implantable medical devices. As this is a general guidance document rather than an enforcement report, it does not name a specific company or list inspection dates and violations; instead, it provides a universal framework for industry compliance. The primary objective is to clarify the criteria for initiating clinical trials to ensure device safety and performance. To facilitate this, the MHRA provides a structured flowchart accompanied by detailed explanatory text. Manufacturers are instructed to prioritize the flowchart to understand the decision-making sequence. Furthermore, the agency requires that this document be used in conjunction with supplementary guidance regarding the definition of a medical device and the formal notification procedures for clinical investigations. By following these steps, manufacturers can ensure they meet legal obligations for clinical evidence before bringing a device to market. The guidance emphasizes a systematic approach to regulatory compliance, focusing on pre-market evaluation requirements to confirm that data supports safety claims.